IDH 305
CAS: 1628805-46-8
Ref. 3D-DQC80546
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Product Information
Name:
IDH 305
Synonyms:
- (4R)-4-[(1S)-1-Fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-2'-(trifluoromethyl) [3,4'-bipyridin]-6-yl]ethyl]amino]-4-pyrimidinyl]-2-oxazolid inone
Description:
IDH 305 is a retinoic acid that is used in the treatment of intrahepatic cholangiocarcinoma (ICC). It has been shown to inhibit cancer cell growth in vitro and in vivo. Retinoic acid binds to cellular retinoic acid receptors, which activate transcription factors that regulate gene expression. The activity of IDH 305 may be due to its ability to inhibit glucose transporters, leading to decreased uptake of glucose into cells and inhibition of histone methylation and DNA synthesis.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
490.45 g/mol
Formula:
C23H22F4N6O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-DQC80546 IDH 305
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
